More to science: working as a Research Funding Manager

This piece was originally published on the BioMed Central blog network, part of Springer Nature.

Pixabay

There’s more to science than being a scientist! Next in our ‘Science > Careers’ series Anne Helme explains more about the path that led to her role as Research Funding Manager at Cancer Research UK.

Science communication: How to deal with the media

Robert Dawson gives scientists a PR 101 at the 2015 London Naturejobs Career Expo.

Top tips:

  1. Understand what your audience wants from you.
  2. Figure out the three key messages.
  3. Practice and volcalize your pitch!

Further reading:

Science communication: Whose responsibility is it?

Science communication: Sculpting your role

Science communication: How to deal with misrepresented science in the media

Science communication: Do you need a PhD?

Science communication: Making the transition

Science communication: How to get a job

The Dominant Malignancy: Lung Cancer

Lung cancer is the leading cause of cancer mortality. In some countries, incidence rates are dropping but survival rates for those with the disease remain low.

A special supplement published in Nature today explores the current risks, therapies and causes of lung cancer.

The Nature Outlook on lung cancer, supported by Cancer Research UK and Boehringer Ingelheim, contains commentaries, features and articles on topics including: the risks and costs associated with lung-cancer screening, therapies targeted at the specific genetics of a patient’s lung cancer, air pollution risks and key lung-cancer mutations in non-smokers.

Here is a snapshot of the striking graphics that can be found in the supplement.

For more graphics, features and information, click through to read the free-to-access Outlook.

Continue reading

The big issues affecting lung cancer worldwide

This blog has been produced in collaboration with Cancer Research UK.

Lung cancer is the biggest cancer killer – both here in the UK and globally.

And although the UK has seen signs of improvement – lung cancer rates in men have dropped by 50 per cent in the last four decades – a huge burden still looms. Over the last 40 years, the number of women being diagnosed with the disease has increased by 75 per cent, largely mirroring trends in smoking from decades ago.

To highlight this continuing challenge, Cancer Research UK has teamed up with Nature, which today publishes a series of articles that touch on some key areas for lung cancer – from research to prevention – from across the globe.

Here’s a summary of what to expect from the Nature Outlook on lung cancer.

The dominant malignancy

In the first article, Eric Bender explores global statistics for lung cancer, including the impact of smoking in the UK, and the worrying rise in men smoking in China. Cancer Research UK’s graphic below shows how lung cancer rates follow the pattern of smoking rates in the UK.

Read more

 

Risk factors: Estimated causes of lung cancer in Britain, 2014. Most cases of lung cancer are attributable to smoking, and so could be prevented.

Risk factors: Estimated causes of lung cancer in Britain, 2014. Most cases of lung cancer are attributable to smoking, and so could be prevented.

Continue reading

Communities Happenings – 29th March

Communities Happenings is a (usually) weekly post with news of interest to NPG’s online communities. The aim is to provide this info in one handy summary. Listings include tweetups and conferences that we’re attending and/or organising as well as new online tools, products or cool videos. We also occasionally flag up NPG special offers and competitions plus updates about NPG social media activities such as new accounts you might want to follow. Do let us know what you find most useful!

SoNYC 

SoNYC is the monthly discussion series which the nature.com Communities team organises in collaboration with Ars Technica and Rockefeller University. The event is also live-streamed and archived and we create a round-up post including a Storify storyboard of all the online conversations around the event.

March 20th’s event was a re-scheduling of last October’s event on, “Setting the research record straight” which focussed on deterring and detecting plagiarism in scientific papers. The panel featured Retraction Watch blogger, Ivan Oransky, John Kreuger of the Office of Research Integrity and Liz Williams, Executive Editor of The Journal of Cell Biology. As we did for February’s event, we posted preview content on Of Schemes and Memes – thanks to Rich van Noorden and Dot Clyde for contributing along with Ivan and others. You can find a write-up of the event from Nature NYC blogger Jennifer Cable here, as well as a Storify collating the online conversation. Here is the take-home message as described by Jennifer Cable:

It was implied in most of the discussion that retractions are a result of bad science, whether or not there was an initial intent to deceive. However, as John Krueger pointed out, retractions are a healthy part of the scientific process and a well-written retraction notice can contribute as much, if not more, to the advancement of science than the initial manuscript. And, as Liz Williams put it,
“If the goal is to preserve the integrity of the scientific literature, then retractions are a sign of progress.”

The next SoNYC event will be the first birthday celebration on Wednesday May 2nd featuring an open mic night for attendees to demo an online tool, app or website that they find useful for communicating or carrying out science online. You can find out more information  about the birthday celebrations, including how to enter, in our summary post. In the meantime, keep an eye on the #SoNYC hashtag and feel free to get in touch if you have any questions.

SoNYC is growing: Announcing SoSEA and SoVan

We’re pleased to be supporting the replication of the SoNYC model in other locations. Over the past week, we’ve announced new events in Seattle and Vancouver, where local organisers are putting together similar monthly meetings. As these events will be livestreamed and enthusiastically tweeted, you’ll be able to join in the conversations wherever you are, or catch up on the video archives and Storifys of tweets afterwards.

Soapbox Science specials 

Last week the Soapbox Science blog featured a special series on alternative sources of funding for scientists. Over the years science funding has changed significantly. Today, researchers are usually funded by a mixture of grants from government agencies, non-profit foundations and institutions. However, with the increasing popularity of social media and the internet, methods used to obtain money may be undergoing a shift. New routes linking funding sources with scientists are being increasingly explored. This special Soapbox Science series focused on the new ways in which science groups and individuals are obtaining funding and how projects such as Petridish, Tekla Labs, and Kickstarter may change the future of scientific researchPosts included:

  • Scientists as global citizens – some ideas for supporting science around the world
  • Interview with Kevin Zelnio whose #IamScience project to turn scientists’ career stories into an ebook was recently funded by Kickstarter
  •  Case studies of 3 scientists, each attempting to fund their projects via Petridish, a new crowdfunding site for science research:
  • Speaking up in support of federally funded research
The London blog also featured an interview with Professor Jack Cuzick , head of the Centre for Epidemiology, Mathematics and Statistics at the Wolfson Institute in London about raising £100,000 of funding using Cancer Research UK’s  “MyProjects” initiative:
MyProjects is a web-based initiative to give members of the public the opportunity to donate to a specific piece of research which is meaningful to them. The projects are described online, with a target of how much money needs to be raised in donations before they will be collected and work will begin. At the moment, 39 projects are seeking or have reached full funding, spanning a whole range of cancers. One of the major beneficiaries of this initiative was Professor Jack Cuzick , head of the Centre for Epidemiology, Mathematics and Statistics at the Wolfson Institute in London, whose major trial of a breast cancer drug raised over £100,000 of funding.

Continue to the post to hear more from Professor Jack Cuzick  as well as a video where he talks about his fund raising goals.  If you have an idea or a someone who might be interested in taking to the Soapbox, please do get in touch.

SciBarCamb tickets

April sees the return of SciBarCamb – an unconference for scientists and technologists, taking place on the evening of Friday 20th April and all day on Saturday 21st. The earlybird tickets have now sold out, but there are still some regular tickets left.  If you’d like to find out more about the event, read what co-organiser Eva Amsen has to say about it and you can follow the online chatter using the #SciBarCamb hashtag.

Nature News wins a Shorty award!

Finally, a big congratulations to the Nature News team who won a Shorty Award this week in the science category! Brendan Maher, News Feature Editor, accepted the award on behalf of the group. You can see the award in all its glory in the (slightly blurry) photos below:

 

The AACR Meeting

Nature will be at the American Association for Cancer Research (AACR) Annual Meeting in Chicago this weekend.

Come visit us at booth #3504, and come play our famousScientific Reports cog wheel game for special prizes. And don’t forget to ask about the exclusive discount 60% discount for AACR attendees! #NATUREatAACR. Do let us know what you think about the conference and any opinions you have.